Multiple drug ingestion by ecstasy abusers in the United States

Journal of Analytical Toxicology

Volumn 33, Issue 3, 2009, Pages 143-147

  Black, David L ^a   Cawthon, Beverly ^a   Robert, Tim ^a   Moser, Frank ^a   Caplan, Yale H ^b   Cone, Edward J ^c,d  

^a Aegis Sciences Corporation   (United States)

^b National Scientific Services   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALPRAZOLAM; AMPHETAMINE; BENZOYLECGONINE; BUTALBITAL; CANNABIS; CODEINE; DIAZEPAM; DIHYDROCODEINE; HYDROCODONE; HYDROMORPHONE; ILLICIT DRUG; METHADONE; METHAMPHETAMINE; MORPHINE; NORDAZEPAM; OPIATE; OXAZEPAM; OXYCODONE; OXYMORPHONE; PHENTERMINE; TEMAZEPAM;

ARTICLE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE DRUG ABUSE; PREVALENCE; PRISON; SPORT; UNITED STATES; URINALYSIS; WORKPLACE;

CANNABIS;

EID: 65749091603     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/33.3.143     Document Type: Article

References (14)

1. Substance Abuse and Mental Health Services Administration. Results from the 2007 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H- 34, DHHS Publication No. SMA 08-4343, Rockville, MD, 2008.
2. DHHS. Proposed revisions to mandatory guidelines for federal workplace drug testing programs. Fed. Regist. 69: 19673-19732 (2004).
3. R. de la Torre, M. Farré, J. Ortuño, M. Mas, R. Brenneisen, P.N. Roset, J. Segura, and J. Camí. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. Br. J. Clin. Pharmacol. 49: 104-109 (2000).
4. H.K. Ensslin, H.H. Maurer, E. Gouzoulis, L. Hermle, and K.A. Kovar. Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Isolation, identification, quantification, and synthesis of urinary metabolites. Drug Metab. Dispos. 24: 813-820 (1996). (Pubitemid 26274737)
5. H. Zhao, R. Brenneisen, A. Scholer, A.J. McNally, M.A. ElSohly, T.P. Murphy, and S.J. Salamone. Profiles of urine samples taken from ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS. J. Anal. Toxicol. 25: 258-269 (2001). (Pubitemid 32466510)
6. C. Hopfer, B. Mendelson, J.M. Van Leeuwen, S. Kelly, and S. Hooks. Club drug use among youths in treatment for substance abuse. Am. J. Addict. 15: 94-99 (2006).
7. L.T. Wu, W.E. Schlenger, and D.M. Galvin. Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths. Drug Alcohol Depend. 84: 102-113 (2006). (Pubitemid 44137307)
8. K.A. Parks and C.L. Kennedy. Club drugs: reasons for and consequences of use. J. Psychoactive Drugs 36: 295-302 (2004).
9. G.S. Yacoubian, Jr., A.M. Arria, E. Fost, and E.D.Wish. Estimating the prevalence of Ecstasy use among juvenile offenders. J. Psychoactive Drugs 34: 209-213 (2002).
10. E.J. Cone, Y.H. Caplan, D.L. Black, T. Robert, and F. Moser. Urine drug testing of chronic pain patients: licit and illicit drug patterns. J. Anal. Toxicol. 32: 530-546 (2008).
11. United Nations Office on Drugs and Crime. Amphetamines and Ecstasy: 2008 Global ATS Assessment. Publication No. E.08.XI.12, 978-92-1-148231-148237, United Nations, New York, NY, 2008.
12. L.D. Johnston, P.M. O'Malley, J.G. Bachman, and J.E. Schulenberg. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2007. NIH Publication No. 08- 6418, National Institute on Drug Abuse, Bethesda, MD, 2008.
13. K.S. Kalasinsky, J. Hugel, and S.J. Kish. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA). J. Forensic Sci. 49: 1106-1112 (2004). (Pubitemid 39166714)
14. B.J. Weimer, D. Peters, C. Sannerud, C. Eicheldinger, J. Ancheta, K. Strom, and V. Rachal. The National Forensic Laboratory Information System: 2006 Annual Report. U.S. Drug Enforcement Administration, Washington, D.C., 2007.